85 related articles for article (PubMed ID: 19740632)
1. Formulation and physicochemical characterization of poly(epsilon-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium.
Arias JL; López-Viota M; Sáez-Fernández E; Ruiz MA
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):204-8. PubMed ID: 19740632
[TBL] [Abstract][Full Text] [Related]
2. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment.
Arias JL; López-Viota M; López-Viota J; Delgado AV
Int J Pharm; 2009 Dec; 382(1-2):270-6. PubMed ID: 19712736
[TBL] [Abstract][Full Text] [Related]
3. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres.
Arias JL; Gallardo V; Ruiz MA; Delgado AV
Int J Pharm; 2007 Jun; 337(1-2):282-90. PubMed ID: 17223292
[TBL] [Abstract][Full Text] [Related]
4. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.
Ortiz R; Cabeza L; Arias JL; Melguizo C; Álvarez PJ; Vélez C; Clares B; Áranega A; Prados J
AAPS J; 2015 Jul; 17(4):918-29. PubMed ID: 25894746
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles: preparation, characterization and potential application in corneal transplantation.
Zhang Z; Xu L; Chen H; Li X
J Pharm Pharmacol; 2014 Apr; 66(4):557-63. PubMed ID: 24635557
[TBL] [Abstract][Full Text] [Related]
6. Aceclofenac-loaded poly-epsilon-caprolactone nanocapsules. Effect of coadjuvants on morphometrical properties and drug entrapment.
Alonso MJ; García ML; Espina M; Valls O; Egea MA
Boll Chim Farm; 2000; 139(3):114-9. PubMed ID: 10961020
[TBL] [Abstract][Full Text] [Related]
7. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
[TBL] [Abstract][Full Text] [Related]
8. Investigation of polymer and nanoparticle properties with nicotinic acid and p-aminobenzoic acid grafted on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) via click chemistry.
Suksiriworapong J; Sripha K; Kreuter J; Junyaprasert VB
Bioconjug Chem; 2011 Apr; 22(4):582-94. PubMed ID: 21375231
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac/biodegradable polymer micelles for ocular applications.
Li X; Zhang Z; Li J; Sun S; Weng Y; Chen H
Nanoscale; 2012 Aug; 4(15):4667-73. PubMed ID: 22732776
[TBL] [Abstract][Full Text] [Related]
10. Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (ε-caprolactone) copolymer micelles for the delivery of curcumin.
Song Z; Zhu W; Song J; Wei P; Yang F; Liu N; Feng R
Drug Deliv; 2015 Jan; 22(1):58-68. PubMed ID: 24725028
[TBL] [Abstract][Full Text] [Related]
11. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
12. One-step preparation of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanoparticles for plasmid DNA delivery.
Huang MJ; Gou ML; Qian ZY; Dai M; Li XY; Cao M; Wang K; Zhao J; Yang JL; Lu Y; Tu MJ; Wei YQ
J Biomed Mater Res A; 2008 Sep; 86(4):979-86. PubMed ID: 18067161
[TBL] [Abstract][Full Text] [Related]
13. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.
Misra R; Acharya S; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine of anastrozole for breast cancer: Physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model.
Shavi GV; Nayak UY; Maliyakkal N; Deshpande PB; Raghavendra R; Kumar AR; Reddya MS; Udupa N; Shrawan B
Life Sci; 2015 Nov; 141():143-55. PubMed ID: 26423561
[TBL] [Abstract][Full Text] [Related]
15. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent.
Singh S; Muthu MS
Nanomedicine (Lond); 2007 Apr; 2(2):233-40. PubMed ID: 17716123
[TBL] [Abstract][Full Text] [Related]
17. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.
Beck-Broichsitter M; Schmehl T; Gessler T; Seeger W; Kissel T
J Control Release; 2012 Feb; 157(3):469-77. PubMed ID: 21930166
[TBL] [Abstract][Full Text] [Related]
18. Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design.
Vuddanda PR; Mishra A; Singh SK; Singh S
Pharm Dev Technol; 2015; 20(5):579-87. PubMed ID: 24831535
[TBL] [Abstract][Full Text] [Related]
19. Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.
Socha M; Sapin A; Damgé C; Maincent P
Drug Deliv; 2009 Nov; 16(8):430-6. PubMed ID: 19839787
[TBL] [Abstract][Full Text] [Related]
20. Design and formulation of trimethylated chitosan-graft-poly(ε-caprolactone) nanoparticles used for gene delivery.
Tang S; Huang Z; Zhang H; Wang Y; Hu Q; Jiang H
Carbohydr Polym; 2014 Jan; 101():104-12. PubMed ID: 24299755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
